The Volpara Health Technologies Ltd (ASX:VHT) share price is storming higher on Thursday after releasing study results from the second round of its DENSE trial…
The post Here’s why the Volpara (ASX:VHT) share price is storming higher appeared first on The Motley Fool Australia. –
The Volpara Health Technologies Ltd (ASX: VHT) share price is on course to record a strong gain on Thursday.
In morning trade, the healthcare technology company’s shares are up a solid 4% to $1.35.
Today’s gain means that the Volpara share price has now risen by over 18% since this time last year.
Why is the Volpara share price storming higher today?
Investors have been buying Volpara’s shares today after it announced the publication of the results of the second round of Project DENSE in Radiology.
The DENSE trial, which is based in the Netherlands, started collecting patients 10 years ago. It is the first randomised controlled study on the clinical utility of breast MRI supplemental screening for women with extremely dense breasts. The study is using the company’s Volpara Density software to assess breast density.
The first results from DENSE trial in December 2019 showed a significant reduction in interval cancers in those women being selected for breast MRI using Volpara Density, but with a relatively high false-positive rate.
Second time around, although the incremental cancer detection rate was lower than that of the first round, the false-positive rate was only 26.3 versus 79.8 per 1000 screening examinations.
Volpara’s CEO Dr Ralph Highnam was pleased with the results and particularly the reduction in false positives being reported.
He said: “The first results from DENSE showed a dramatic decrease in the number of interval cancers by varying screening based upon VolparaDensity. These follow-up results demonstrate that as screening programs settle into these new protocols, the number of false positives is significantly reduced and makes the new protocol much more viable.”
“We are incredibly proud to be part of this work, which has been a 10-year journey for us and the investigators but is showing a real benefit to women,” Dr Highnam concluded.
Where to invest $1,000 right now
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.
*Returns as of February 15th 2021
- 3 ASX Healthcare shares feeling a little under the weather
- Here’s why the Volpara (ASX:VHT) share price is surging 7% higher
- Why Flight Centre, Qantas, ResApp, & Volpara are racing higher
- Why the Volpara (ASX:VHT) share price is pushing higher today
- Is it time to buy these 2 hot ASX healthcare shares?
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends VOLPARA FPO NZ. The Motley Fool Australia has recommended VOLPARA FPO NZ. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.